• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immunomodulatory analogs of thalidomide: an emerging new therapy in myeloma.

作者信息

Richardson Paul, Anderson Kenneth

出版信息

J Clin Oncol. 2004 Aug 15;22(16):3212-4. doi: 10.1200/JCO.2004.05.984. Epub 2004 Jul 12.

DOI:10.1200/JCO.2004.05.984
PMID:15249587
Abstract
摘要

相似文献

1
Immunomodulatory analogs of thalidomide: an emerging new therapy in myeloma.沙利度胺的免疫调节类似物：骨髓瘤治疗的新兴疗法
J Clin Oncol. 2004 Aug 15;22(16):3212-4. doi: 10.1200/JCO.2004.05.984. Epub 2004 Jul 12.
2
Thalidomide and immunomodulatory drugs as cancer therapy.沙利度胺及免疫调节药物用于癌症治疗
Curr Opin Oncol. 2002 Nov;14(6):635-40. doi: 10.1097/00001622-200211000-00008.
3
Immunomodulatory drugs.免疫调节药物。
Cancer Invest. 2005;23(7):625-34. doi: 10.1080/07357900500283101.
4
Immunomodulatory analogues of thalidomide in the treatment of multiple myeloma.
Clin Lymphoma Myeloma. 2006 Jan;6(4):301-5. doi: 10.3816/CLM.2006.n.004.
5
Mechanism of action of immunomodulatory agents in multiple myeloma.免疫调节剂在多发性骨髓瘤中的作用机制。
Med Oncol. 2010 Jun;27 Suppl 1(Suppl 1):S7-13. doi: 10.1007/s12032-010-9527-y. Epub 2010 Apr 20.
6
[Pomalidomide for multiple myeloma].泊马度胺用于治疗多发性骨髓瘤
Bull Cancer. 2017 Sep;104(9):707-713. doi: 10.1016/j.bulcan.2017.04.005. Epub 2017 Jun 2.
7
Update on immunomodulatory drugs (IMiDs) in hematologic and solid malignancies.血液系统恶性肿瘤和实体瘤中免疫调节药物（IMiDs）的最新进展。
Expert Opin Pharmacother. 2012 Mar;13(4):473-94. doi: 10.1517/14656566.2012.656091. Epub 2012 Feb 13.
8
[How I treat... refractory multiple myeloma with thalidomide].[我如何用沙利度胺治疗……难治性多发性骨髓瘤]
Rev Med Liege. 2000 Nov;55(11):970-3.
9
Osteoprogenitor differentiation is not affected by immunomodulatory thalidomide analogs but is promoted by low bortezomib concentration, while both agents suppress osteoclast differentiation.骨祖细胞分化不受免疫调节性沙利度胺类似物的影响，但低浓度硼替佐米可促进其分化，而这两种药物均可抑制破骨细胞分化。
Int J Oncol. 2008 Jul;33(1):129-36.
10
[Thalidomide: the revival].[沙利度胺：复兴]
Rev Med Interne. 2001 Jan;22(1):5-7. doi: 10.1016/s0248-8663(00)00279-4.

引用本文的文献

1
The histone deacetylase inhibitor romidepsin synergizes with lenalidomide and enhances tumor cell death in T-cell lymphoma cell lines.组蛋白去乙酰化酶抑制剂罗米地辛与来那度胺协同作用，增强T细胞淋巴瘤细胞系中的肿瘤细胞死亡。
Cancer Biol Ther. 2016 Oct 2;17(10):1094-1106. doi: 10.1080/15384047.2016.1219820. Epub 2016 Sep 22.
2
Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21(WAF1/Cip1)-dependent mechanism independent of functional p53.来那度胺通过一种依赖于cereblon/p21（WAF1/Cip1）且独立于功能性p53的机制抑制慢性淋巴细胞白血病（CLL）细胞的增殖。
Blood. 2014 Sep 4;124(10):1637-44. doi: 10.1182/blood-2014-03-559591. Epub 2014 Jul 2.
3
Identification of a promising PI3K inhibitor for the treatment of multiple myeloma through the structural optimization.
通过结构优化鉴定一种有前景的用于治疗多发性骨髓瘤的PI3K抑制剂。
J Hematol Oncol. 2014 Jan 15;7:9. doi: 10.1186/1756-8722-7-9.
4
The rise, fall and subsequent triumph of thalidomide: lessons learned in drug development.沙利度胺的兴衰及其后续的成功：药物研发中的经验教训。
Ther Adv Hematol. 2011 Oct;2(5):291-308. doi: 10.1177/2040620711413165.
5
Trace determination of lenalidomide in plasma by non-extractive HPLC procedures with fluorescence detection after pre-column derivatization with fluorescamine.采用荧光胺柱前衍生化后通过非萃取高效液相色谱法结合荧光检测对血浆中沙利度胺进行痕量测定。
Chem Cent J. 2013 Mar 14;7(1):52. doi: 10.1186/1752-153X-7-52.
6
Development and validation of ultra-performance liquid chromatographic method with tandem mass spectrometry for determination of lenalidomide in rabbit and human plasma.超高效液相色谱-串联质谱法测定兔和人血浆中来那度胺的方法开发与验证
Chem Cent J. 2013 Jan 14;7(1):7. doi: 10.1186/1752-153X-7-7.
7
Synthesis of hapten and preparation of specific polyclonal antibody with high affinity for lenalidomide, the potent drug for treatment of multiple myeloma.来那度胺是治疗多发性骨髓瘤的有效药物，制备对其具有高亲和力的半抗原并制备特异性多克隆抗体。
Chem Cent J. 2012 Oct 26;6(1):125. doi: 10.1186/1752-153X-6-125.
8
A highly sensitive fluorimetric method for determination of lenalidomide in its bulk form and capsules via derivatization with fluorescamine.一种通过与荧光胺衍生化来测定来那度胺原料药及其胶囊中含量的高灵敏度荧光法。
Chem Cent J. 2012 Oct 16;6(1):118. doi: 10.1186/1752-153X-6-118.
9
Treatment of relapsed and refractory myeloma.复发性和难治性骨髓瘤的治疗。
Curr Hematol Malig Rep. 2009 Apr;4(2):99-107. doi: 10.1007/s11899-009-0014-5.
10
Thalidomide and lenalidomide as new therapeutics for the treatment of chronic lymphocytic leukemia.沙利度胺和来那度胺作为治疗慢性淋巴细胞白血病的新疗法。
Leuk Lymphoma. 2010 Jan;51(1):27-38. doi: 10.3109/10428190903350405.